With $3.2M Funding, Sonomind Moves Toward FDA Talks, Eyes De Novo Pathway For US Market Entry

Paris start-up splits funding between R&D and first-in-human trials; Series A planned for 2026.

 
• By Shubham Singh
  
The company designed a 3D-printed acoustic lens. Each lens is custom-built using imaging of the patient’s skull morphology, enabling ultrasound beams to be corrected and focused through bone with millimeter precision. Picture Courtesy: Sonomind

More from Financing

More from Business